APO Research
Talk to an analyst

APO RESEARCH · REPORT

Finasteride Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Finasteride Preparations Industry Growth and Trends Forecast to 2032

28 December 2025112 pages

Choose your research edition.

Industry ResearchFinasteride Preparations Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Finasteride Preparations Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Finasteride Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Finasteride Preparations Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Finasteride Preparations Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Finasteride Preparations market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Finasteride Preparations include Zhejiang Xianju Pharmaceutical, Grand Pharmaceutical, Topfond Pharmaceutical, Shanghai Shyndec Pharmaceutical, Humanwell Pharmaceutical, Zhejiang Conba Pharmaceutical, CR Double-Crane, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Finasteride Preparations market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Finasteride Preparations market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Finasteride Preparations market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Finasteride Preparations.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Finasteride Preparations market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Finasteride Preparations Market by Company

Zhejiang Xianju Pharmaceutical

Grand Pharmaceutical

Topfond Pharmaceutical

Shanghai Shyndec Pharmaceutical

Humanwell Pharmaceutical

Zhejiang Conba Pharmaceutical

CR Double-Crane

Zydus

Teva

Sun Pharma

Organon

Hetero

Dr. Reddy's Laboratories

Aurobindo Pharma

Alkem

Accord Healthcare

Finasteride Preparations Segment by Type

Capsules

Tablets

Finasteride Preparations Segment by Application

Male Pattern Baldness

Benign Prostatic Hyperplasia (BPH)

Other

Finasteride Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Finasteride Preparations manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Finasteride Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Tablets Table 3. Global Finasteride Preparations Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 5. Global Finasteride Preparations Sales Market Share in Volume by Type (2021-2026) Table 6. Global Finasteride Preparations Sales by Type (2021-2026) & (US$ Million) Table 7. Global Finasteride Preparations Sales Market Share in Value by Type (2021-2026) Table 8. Global Finasteride Preparations Price by Type (2021-2026) & (US$/Unit) Table 9. Global Finasteride Preparations Sales by Type (2027-2032) & (K Units) Table 10. Global Finasteride Preparations Sales Market Share in Volume by Type (2027-2032) Table 11. Global Finasteride Preparations Sales by Type (2027-2032) & (US$ Million) Table 12. Global Finasteride Preparations Sales Market Share in Value by Type (2027-2032) Table 13. Global Finasteride Preparations Price by Type (2027-2032) & (US$/Unit) Table 14. North America Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 15. North America Finasteride Preparations Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 17. Europe Finasteride Preparations Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Finasteride Preparations Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 21. Latin America Finasteride Preparations Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Finasteride Preparations Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Finasteride Preparations Sales by Type (2021-2026) & (US$ Million) Table 24. Finasteride Preparations Industry Trends Table 25. Finasteride Preparations Industry Drivers Table 26. Finasteride Preparations Industry Opportunities and Challenges Table 27. Finasteride Preparations Industry Restraints Table 28. Global Finasteride Preparations Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Finasteride Preparations Revenue Market Share by Company (2021-2026) Table 30. Global Finasteride Preparations Sales by Company (2021-2026) & (K Units) Table 31. Global Finasteride Preparations Sales Share by Company (2021-2026) Table 32. Global Finasteride Preparations Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Finasteride Preparations Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Finasteride Preparations Major Company Production Sites and Headquarters Table 35. Global Finasteride Preparations Company, Product Type & Application Table 36. Global Finasteride Preparations Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Finasteride Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Finasteride Preparations Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Finasteride Preparations Sales by Region (2021-2026) & (K Units) Table 41. Global Finasteride Preparations Sales Market Share in Volume by Region (2021-2026) Table 42. Global Finasteride Preparations Sales by Region (2021-2026) & (US$ Million) Table 43. Global Finasteride Preparations Sales Market Share in Value by Region (2021-2026) Table 44. Global Finasteride Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Finasteride Preparations Sales by Region (2027-2032) & (K Units) Table 46. Global Finasteride Preparations Sales Market Share in Volume by Region (2027-2032) Table 47. Global Finasteride Preparations Sales by Region (2027-2032) & (US$ Million) Table 48. Global Finasteride Preparations Sales Market Share in Value by Region (2027-2032) Table 49. Global Finasteride Preparations Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Finasteride Preparations Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 52. Global Finasteride Preparations Sales Market Share in Volume by Application (2021-2026) Table 53. Global Finasteride Preparations Sales by Application (2021-2026) & (US$ Million) Table 54. Global Finasteride Preparations Sales Market Share in Value by Application (2021-2026) Table 55. Global Finasteride Preparations Price by Application (2021-2026) & (US$/Unit) Table 56. Global Finasteride Preparations Sales by Application (2027-2032) & (K Units) Table 57. Global Finasteride Preparations Sales Market Share in Volume by Application (2027-2032) Table 58. Global Finasteride Preparations Sales by Application (2027-2032) & (US$ Million) Table 59. Global Finasteride Preparations Sales Market Share in Value by Application (2027-2032) Table 60. Global Finasteride Preparations Price by Application (2027-2032) & (US$/Unit) Table 61. North America Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 62. North America Finasteride Preparations Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 64. Europe Finasteride Preparations Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Finasteride Preparations Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 68. Latin America Finasteride Preparations Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Finasteride Preparations Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Finasteride Preparations Sales by Application (2021-2026) & (US$ Million) Table 71. Zhejiang Xianju Pharmaceutical Company Information Table 72. Zhejiang Xianju Pharmaceutical Business Overview Table 73. Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zhejiang Xianju Pharmaceutical Finasteride Preparations Product Portfolio Table 75. Zhejiang Xianju Pharmaceutical Recent Development Table 76. Grand Pharmaceutical Company Information Table 77. Grand Pharmaceutical Business Overview Table 78. Grand Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Grand Pharmaceutical Finasteride Preparations Product Portfolio Table 80. Grand Pharmaceutical Recent Development Table 81. Topfond Pharmaceutical Company Information Table 82. Topfond Pharmaceutical Business Overview Table 83. Topfond Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Topfond Pharmaceutical Finasteride Preparations Product Portfolio Table 85. Topfond Pharmaceutical Recent Development Table 86. Shanghai Shyndec Pharmaceutical Company Information Table 87. Shanghai Shyndec Pharmaceutical Business Overview Table 88. Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanghai Shyndec Pharmaceutical Finasteride Preparations Product Portfolio Table 90. Shanghai Shyndec Pharmaceutical Recent Development Table 91. Humanwell Pharmaceutical Company Information Table 92. Humanwell Pharmaceutical Business Overview Table 93. Humanwell Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Humanwell Pharmaceutical Finasteride Preparations Product Portfolio Table 95. Humanwell Pharmaceutical Recent Development Table 96. Zhejiang Conba Pharmaceutical Company Information Table 97. Zhejiang Conba Pharmaceutical Business Overview Table 98. Zhejiang Conba Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Zhejiang Conba Pharmaceutical Finasteride Preparations Product Portfolio Table 100. Zhejiang Conba Pharmaceutical Recent Development Table 101. CR Double-Crane Company Information Table 102. CR Double-Crane Business Overview Table 103. CR Double-Crane Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CR Double-Crane Finasteride Preparations Product Portfolio Table 105. CR Double-Crane Recent Development Table 106. Zydus Company Information Table 107. Zydus Business Overview Table 108. Zydus Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus Finasteride Preparations Product Portfolio Table 110. Zydus Recent Development Table 111. Teva Company Information Table 112. Teva Business Overview Table 113. Teva Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Teva Finasteride Preparations Product Portfolio Table 115. Teva Recent Development Table 116. Sun Pharma Company Information Table 117. Sun Pharma Business Overview Table 118. Sun Pharma Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sun Pharma Finasteride Preparations Product Portfolio Table 120. Sun Pharma Recent Development Table 121. Organon Company Information Table 122. Organon Business Overview Table 123. Organon Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Organon Finasteride Preparations Product Portfolio Table 125. Organon Recent Development Table 126. Hetero Company Information Table 127. Hetero Business Overview Table 128. Hetero Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hetero Finasteride Preparations Product Portfolio Table 130. Hetero Recent Development Table 131. Dr. Reddy's Laboratories Company Information Table 132. Dr. Reddy's Laboratories Business Overview Table 133. Dr. Reddy's Laboratories Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Dr. Reddy's Laboratories Finasteride Preparations Product Portfolio Table 135. Dr. Reddy's Laboratories Recent Development Table 136. Aurobindo Pharma Company Information Table 137. Aurobindo Pharma Business Overview Table 138. Aurobindo Pharma Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Aurobindo Pharma Finasteride Preparations Product Portfolio Table 140. Aurobindo Pharma Recent Development Table 141. Alkem Company Information Table 142. Alkem Business Overview Table 143. Alkem Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Alkem Finasteride Preparations Product Portfolio Table 145. Alkem Recent Development Table 146. Accord Healthcare Company Information Table 147. Accord Healthcare Business Overview Table 148. Accord Healthcare Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Accord Healthcare Finasteride Preparations Product Portfolio Table 150. Accord Healthcare Recent Development Table 151. North America Finasteride Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. North America Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 153. North America Finasteride Preparations Sales Market Share by Country (2021-2026) Table 154. North America Finasteride Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 155. North America Finasteride Preparations Sales Market Share Forecast by Country (2027-2032) Table 156. North America Finasteride Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Finasteride Preparations Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Finasteride Preparations Market Share by Country (2021-2026) Table 159. North America Finasteride Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Finasteride Preparations Market Share Forecast by Country (2027-2032) Table 161. Europe Finasteride Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Europe Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 163. Europe Finasteride Preparations Sales Market Share by Country (2021-2026) Table 164. Europe Finasteride Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 165. Europe Finasteride Preparations Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Finasteride Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Finasteride Preparations Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Finasteride Preparations Market Share by Country (2021-2026) Table 169. Europe Finasteride Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Finasteride Preparations Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Finasteride Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 173. Asia-Pacific Finasteride Preparations Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Finasteride Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 175. Asia-Pacific Finasteride Preparations Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Finasteride Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Finasteride Preparations Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Finasteride Preparations Market Share by Country (2021-2026) Table 179. Asia-Pacific Finasteride Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Finasteride Preparations Market Share Forecast by Country (2027-2032) Table 181. Latin America Finasteride Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Latin America Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 183. Latin America Finasteride Preparations Sales Market Share by Country (2021-2026) Table 184. Latin America Finasteride Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 185. Latin America Finasteride Preparations Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Finasteride Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Finasteride Preparations Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Finasteride Preparations Market Share by Country (2021-2026) Table 189. Latin America Finasteride Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Finasteride Preparations Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Finasteride Preparations Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Finasteride Preparations Sales by Country (2021-2026) & (K Units) Table 193. Middle East and Africa Finasteride Preparations Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Finasteride Preparations Sales Forecast by Country (2027-2032) & (K Units) Table 195. Middle East and Africa Finasteride Preparations Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Finasteride Preparations Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Finasteride Preparations Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Finasteride Preparations Market Share by Country (2021-2026) Table 199. Middle East and Africa Finasteride Preparations Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Finasteride Preparations Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Finasteride Preparations Distributors List Table 204. Finasteride Preparations Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Finasteride Preparations Image Figure 2. Global Finasteride Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Preparations Market Size (2021-2032) & (US$ Million) Figure 4. Global Finasteride Preparations Sales (2021-2032) & (K Units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Finasteride Preparations Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Finasteride Preparations Market Share by Type 2025 VS 2032 Figure 11. North America Finasteride Preparations Sales Market Share in Volume by Type in 2025 Figure 12. North America Finasteride Preparations Sales Market Share in Value by Type in 2025 Figure 13. Europe Finasteride Preparations Sales Market Share in Volume by Type in 2025 Figure 14. Europe Finasteride Preparations Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Finasteride Preparations Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Finasteride Preparations Sales Market Share in Value by Type in 2025 Figure 17. Latin America Finasteride Preparations Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Finasteride Preparations Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Finasteride Preparations Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Finasteride Preparations Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Finasteride Preparations Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Male Pattern Baldness Image Figure 24. Global Male Pattern Baldness Sales YoY Growth (2021-2032) & (K Units) Figure 25. Benign Prostatic Hyperplasia (BPH) Image Figure 26. Global Benign Prostatic Hyperplasia (BPH) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Finasteride Preparations Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Finasteride Preparations Market Share by Application 2025 VS 2032 Figure 31. North America Finasteride Preparations Sales Market Share in Volume by Application in 2025 Figure 32. North America Finasteride Preparations Sales Market Share in Value by Application in 2025 Figure 33. Europe Finasteride Preparations Sales Market Share in Volume by Application in 2025 Figure 34. Europe Finasteride Preparations Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Finasteride Preparations Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Finasteride Preparations Sales Market Share in Value by Application in 2025 Figure 37. Latin America Finasteride Preparations Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Finasteride Preparations Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Finasteride Preparations Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Finasteride Preparations Sales Market Share in Value by Application in 2025 Figure 41. North America Finasteride Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Finasteride Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Finasteride Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Finasteride Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Finasteride Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Finasteride Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Finasteride Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Finasteride Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Finasteride Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Finasteride Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Finasteride Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Finasteride Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Finasteride Preparations Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Finasteride Preparations Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Finasteride Preparations Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Finasteride Preparations Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Finasteride Preparations Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
Applications
  • Male Pattern Baldness
  • Benign Prostatic Hyperplasia (BPH)
  • Other
Companies covered
  • Zhejiang Xianju Pharmaceutical
  • Grand Pharmaceutical
  • Topfond Pharmaceutical
  • Shanghai Shyndec Pharmaceutical
  • Humanwell Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • CR Double-Crane
  • Zydus
  • Teva
  • Sun Pharma
  • Organon
  • Hetero
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • Alkem
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Finasteride Preparations Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Finasteride Preparations Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Finasteride Preparations Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Tablets
  8. 1.4 Global Finasteride Preparations Market Size by Type
  9. 1.4.1 Global Finasteride Preparations Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Finasteride Preparations Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Finasteride Preparations Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Finasteride Preparations Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Finasteride Preparations Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Finasteride Preparations Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Finasteride Preparations Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Finasteride Preparations Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Finasteride Preparations Industry Trends
  2. 2.2 Finasteride Preparations Industry Drivers
  3. 2.3 Finasteride Preparations Industry Opportunities and Challenges
  4. 2.4 Finasteride Preparations Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Finasteride Preparations Revenue (2021-2026)
  2. 3.2 Global Top Players by Finasteride Preparations Sales (2021-2026)
  3. 3.3 Global Top Players by Finasteride Preparations Price (2021-2026)
  4. 3.4 Global Finasteride Preparations Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Finasteride Preparations Major Company Production Sites & Headquarters
  6. 3.6 Global Finasteride Preparations Company, Product Type & Application
  7. 3.7 Global Finasteride Preparations Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Finasteride Preparations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Finasteride Preparations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Finasteride Preparations Tier 1, Tier 2, and Tier 3
4 Finasteride Preparations Regional Status and Outlook
  1. 4.1 Global Finasteride Preparations Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Finasteride Preparations Historic Market Size by Region
  3. 4.2.1 Global Finasteride Preparations Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Finasteride Preparations Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Finasteride Preparations Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Finasteride Preparations Forecasted Market Size by Region
  7. 4.3.1 Global Finasteride Preparations Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Finasteride Preparations Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Finasteride Preparations Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Finasteride Preparations by Application
  1. 5.1 Finasteride Preparations Market by Application
  2. 5.1.1 Male Pattern Baldness
  3. 5.1.2 Benign Prostatic Hyperplasia (BPH)
  4. 5.1.3 Other
  5. 5.2 Global Finasteride Preparations Market Size by Application
  6. 5.2.1 Global Finasteride Preparations Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Finasteride Preparations Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Finasteride Preparations Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Finasteride Preparations Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Finasteride Preparations Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Finasteride Preparations Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Finasteride Preparations Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Finasteride Preparations Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Xianju Pharmaceutical
  2. 6.1.1 Zhejiang Xianju Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Xianju Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Xianju Pharmaceutical Finasteride Preparations Product Portfolio
  6. 6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
  7. 6.2 Grand Pharmaceutical
  8. 6.2.1 Grand Pharmaceutical Company Information
  9. 6.2.2 Grand Pharmaceutical Business Overview
  10. 6.2.3 Grand Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grand Pharmaceutical Finasteride Preparations Product Portfolio
  12. 6.2.5 Grand Pharmaceutical Recent Developments
  13. 6.3 Topfond Pharmaceutical
  14. 6.3.1 Topfond Pharmaceutical Company Information
  15. 6.3.2 Topfond Pharmaceutical Business Overview
  16. 6.3.3 Topfond Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Topfond Pharmaceutical Finasteride Preparations Product Portfolio
  18. 6.3.5 Topfond Pharmaceutical Recent Developments
  19. 6.4 Shanghai Shyndec Pharmaceutical
  20. 6.4.1 Shanghai Shyndec Pharmaceutical Company Information
  21. 6.4.2 Shanghai Shyndec Pharmaceutical Business Overview
  22. 6.4.3 Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Shyndec Pharmaceutical Finasteride Preparations Product Portfolio
  24. 6.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
  25. 6.5 Humanwell Pharmaceutical
  26. 6.5.1 Humanwell Pharmaceutical Company Information
  27. 6.5.2 Humanwell Pharmaceutical Business Overview
  28. 6.5.3 Humanwell Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Humanwell Pharmaceutical Finasteride Preparations Product Portfolio
  30. 6.5.5 Humanwell Pharmaceutical Recent Developments
  31. 6.6 Zhejiang Conba Pharmaceutical
  32. 6.6.1 Zhejiang Conba Pharmaceutical Company Information
  33. 6.6.2 Zhejiang Conba Pharmaceutical Business Overview
  34. 6.6.3 Zhejiang Conba Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zhejiang Conba Pharmaceutical Finasteride Preparations Product Portfolio
  36. 6.6.5 Zhejiang Conba Pharmaceutical Recent Developments
  37. 6.7 CR Double-Crane
  38. 6.7.1 CR Double-Crane Company Information
  39. 6.7.2 CR Double-Crane Business Overview
  40. 6.7.3 CR Double-Crane Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CR Double-Crane Finasteride Preparations Product Portfolio
  42. 6.7.5 CR Double-Crane Recent Developments
  43. 6.8 Zydus
  44. 6.8.1 Zydus Company Information
  45. 6.8.2 Zydus Business Overview
  46. 6.8.3 Zydus Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Finasteride Preparations Product Portfolio
  48. 6.8.5 Zydus Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Finasteride Preparations Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Sun Pharma
  56. 6.10.1 Sun Pharma Company Information
  57. 6.10.2 Sun Pharma Business Overview
  58. 6.10.3 Sun Pharma Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharma Finasteride Preparations Product Portfolio
  60. 6.10.5 Sun Pharma Recent Developments
  61. 6.11 Organon
  62. 6.11.1 Organon Company Information
  63. 6.11.2 Organon Business Overview
  64. 6.11.3 Organon Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Organon Finasteride Preparations Product Portfolio
  66. 6.11.5 Organon Recent Developments
  67. 6.12 Hetero
  68. 6.12.1 Hetero Company Information
  69. 6.12.2 Hetero Business Overview
  70. 6.12.3 Hetero Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hetero Finasteride Preparations Product Portfolio
  72. 6.12.5 Hetero Recent Developments
  73. 6.13 Dr. Reddy's Laboratories
  74. 6.13.1 Dr. Reddy's Laboratories Company Information
  75. 6.13.2 Dr. Reddy's Laboratories Business Overview
  76. 6.13.3 Dr. Reddy's Laboratories Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dr. Reddy's Laboratories Finasteride Preparations Product Portfolio
  78. 6.13.5 Dr. Reddy's Laboratories Recent Developments
  79. 6.14 Aurobindo Pharma
  80. 6.14.1 Aurobindo Pharma Company Information
  81. 6.14.2 Aurobindo Pharma Business Overview
  82. 6.14.3 Aurobindo Pharma Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aurobindo Pharma Finasteride Preparations Product Portfolio
  84. 6.14.5 Aurobindo Pharma Recent Developments
  85. 6.15 Alkem
  86. 6.15.1 Alkem Company Information
  87. 6.15.2 Alkem Business Overview
  88. 6.15.3 Alkem Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Alkem Finasteride Preparations Product Portfolio
  90. 6.15.5 Alkem Recent Developments
  91. 6.16 Accord Healthcare
  92. 6.16.1 Accord Healthcare Company Information
  93. 6.16.2 Accord Healthcare Business Overview
  94. 6.16.3 Accord Healthcare Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Accord Healthcare Finasteride Preparations Product Portfolio
  96. 6.16.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Finasteride Preparations Sales by Country
  2. 7.1.1 North America Finasteride Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Finasteride Preparations Sales by Country (2021-2026)
  4. 7.1.3 North America Finasteride Preparations Sales Forecast by Country (2027-2032)
  5. 7.2 North America Finasteride Preparations Market Size by Country
  6. 7.2.1 North America Finasteride Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Finasteride Preparations Market Size by Country (2021-2026)
  8. 7.2.3 North America Finasteride Preparations Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Finasteride Preparations Sales by Country
  2. 8.1.1 Europe Finasteride Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Finasteride Preparations Sales by Country (2021-2026)
  4. 8.1.3 Europe Finasteride Preparations Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Finasteride Preparations Market Size by Country
  6. 8.2.1 Europe Finasteride Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Finasteride Preparations Market Size by Country (2021-2026)
  8. 8.2.3 Europe Finasteride Preparations Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Finasteride Preparations Sales by Country
  2. 9.1.1 Asia-Pacific Finasteride Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Finasteride Preparations Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Finasteride Preparations Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Finasteride Preparations Market Size by Country
  6. 9.2.1 Asia-Pacific Finasteride Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Finasteride Preparations Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Finasteride Preparations Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Finasteride Preparations Sales by Country
  2. 10.1.1 South America Finasteride Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Finasteride Preparations Sales by Country (2021-2026)
  4. 10.1.3 South America Finasteride Preparations Sales Forecast by Country (2027-2032)
  5. 10.2 South America Finasteride Preparations Market Size by Country
  6. 10.2.1 South America Finasteride Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Finasteride Preparations Market Size by Country (2021-2026)
  8. 10.2.3 South America Finasteride Preparations Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Finasteride Preparations Sales by Country
  2. 11.1.1 Middle East and Africa Finasteride Preparations Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Finasteride Preparations Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Finasteride Preparations Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Finasteride Preparations Market Size by Country
  6. 11.2.1 Middle East and Africa Finasteride Preparations Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Finasteride Preparations Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Finasteride Preparations Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Finasteride Preparations Value Chain Analysis
  2. 12.1.1 Finasteride Preparations Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Finasteride Preparations Production Mode & Process
  7. 12.2 Finasteride Preparations Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Finasteride Preparations Distributors
  10. 12.2.3 Finasteride Preparations Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst